What about the application of lipid nanovectors in Parkinson’s disease?

What about the application of lipid nanovectors in Parkinson’s disease?

Show other versions (1)

Nombreux sont les travaux consacrés au développement des thérapies innovantes pour le traitement de la maladie de Parkinson. L’encapsulation de la dopamine, de la L-DOPA ou des agonistes dopaminergiques dans des nano-vecteurs lipidiques vise à pallier les diverses limites rencontrées lors de l’admi...

Full description

Bibliographic Details
Main Authors:	Sihem BOULENOUAR, Nassima MOUSSAOUI
Format:	Article
Language:	English
Published:	University of Oran 1 2020-12-01
Series:	Journal de la Faculté de Médecine d'Oran
Online Access:	https://www.ajol.info/index.php/jfmo/article/view/226769

Similar Items

What about the application of lipid nanovectors in Parkinson’s disease?
by: Sihem BOULENOUAR, et al.
Published: (2020-12-01)

The Landscape of Nanovectors for Modulation in Cancer Immunotherapy
by: Simona-Ruxandra Volovat, et al.
Published: (2022-02-01)

The Promising Nanovectors for Gene Delivery in Plant Genome Engineering
by: Heng Zhi, et al.
Published: (2022-07-01)

Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors
by: Baltazar Hiram Leal, et al.
Published: (2022-01-01)

Stabilized Reversed Polymeric Micelles as Nanovector for Hydrophilic Compounds
by: Mariacristina Gagliardi, et al.
Published: (2023-02-01)

Structuring and De-Structuring of Nanovectors from Algal Lipids: Simulated Digestion, Preliminary Antioxidant Capacity and In Vitro Tests
by: Ilaria Clemente, et al.
Published: (2022-09-01)

Engineered Polymeric Nanovector for Intracellular Peptide Delivery in Antitumor Therapy
by: Zhang X, et al.
Published: (2023-09-01)

Latest Advances in Biomimetic Cell Membrane-Coated and Membrane-Derived Nanovectors for Biomedical Applications
by: Riccardo Rampado, et al.
Published: (2022-05-01)

Protein Expression Knockdown in Cancer Cells Induced by a Gemini Cationic Lipid Nanovector with Histidine-Based Polar Heads
by: Natalia Sánchez-Arribas, et al.
Published: (2020-08-01)

Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.
by: Viola, JR, et al.
Published: (2010)

Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors
by: Hina Qamar, et al.
Published: (2021-01-01)

Gemini Cationic Lipid-Type Nanovectors Suitable for the Transfection of Therapeutic Plasmid DNA Encoding for Pro-Inflammatory Cytokine Interleukin-12
by: Natalia Sánchez-Arribas, et al.
Published: (2021-05-01)

Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes
by: Kenneth Omabe, et al.
Published: (2021-04-01)

Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments
by: Stephen J. Winter, et al.
Published: (2021-11-01)

Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation
by: Marina Saresella, et al.
Published: (2023-12-01)

Bioinspired Platelet-like Nanovector for Enhancing Cancer Therapy via P-Selectin Targeting
by: Shengli Wan, et al.
Published: (2022-11-01)

Nanoscale Surface-Enhanced Raman Spectroscopy Investigation of a Polyphenol-Based Plasmonic Nanovector
by: Giacomo Nisini, et al.
Published: (2023-01-01)

What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
by: Jinsong Xue, et al.
Published: (2024-01-01)

What Do We Know about Theory of Mind Impairment in Parkinson’s Disease?
by: Clara Trompeta, et al.
Published: (2021-09-01)

The Role of Lipids in Parkinson’s Disease
by: Helena Xicoy, et al.
Published: (2019-01-01)

Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease
by: Charleine Zussy, et al.
Published: (2022-04-01)

Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer
by: Huang Wen, et al.
Published: (2023-10-01)

New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors
by: Fabiola V. Borbolla-Jiménez, et al.
Published: (2021-07-01)

Scaffold of Selenium Nanovectors and Honey Phytochemicals for Inhibition of Pseudomonas aeruginosa Quorum Sensing and Biofilm Formation
by: Prateeksha, et al.
Published: (2017-03-01)

What Is Wrong with Balance in Parkinson’s Disease?
by: Jeong-Ho Park, et al.
Published: (2015-09-01)

Spectroscopic Assessment of Doxorubicin (DOX)-Gemcitabine (GEM) Gold Complex Nanovector as Diagnostic Tool of Galectin-1 Biomarker
by: Khan M, et al.
Published: (2024-03-01)

Multiple-Gene Regulation for Enhanced Antitumor Efficacy with Branch-PCR-Assembled TP53 and MYC Gene Nanovector
by: Longhuai Cheng, et al.
Published: (2022-10-01)

Parkinson’s Disease-Related Genes and Lipid Alteration
by: Milena Fais, et al.
Published: (2021-07-01)

Apport de l’échelle nanométrique en thérapie photodynamique,la lumière à l’assaut du cancer:quoi de neuf?
by: Khadidja Yanalah, et al.
Published: (2022-04-01)

Quand le langage du silence sculpte la diaspora dans les littératures francophones, le cas de ru de Kim THÙY et Madame l’Afrique de Eugène ÉBODÉ
by: Halima MOUSSAOUI & Nassima DJEBBARI
Published: (2023-09-01)

Parkinson's disease: The dirty truth about the air
by: Fulvio A Scorza, et al.
Published: (2023-01-01)

Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin
by: Valentina Del Genio, et al.
Published: (2022-07-01)

Polymeric Nanovectors Incorporated with Ganciclovir and HSV-<i>tk</i> Encoding Plasmid for Gene-Directed Enzyme Prodrug Therapy
by: Alicia J. Sawdon, et al.
Published: (2021-03-01)

Step-by-Step Design of New Theranostic Nanoformulations: Multifunctional Nanovectors for Radio-Chemo-Hyperthermic Therapy under Physical Targeting
by: Shoeb Anwar Ansari, et al.
Published: (2021-07-01)

Lipid Nanoparticles: Promising Treatment Approach for Parkinson’s Disease
by: Keelan Jagaran, et al.
Published: (2022-08-01)

LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
by: Jasmin Galper, et al.
Published: (2022-10-01)

What Can Mushroom Proteins Teach Us about Lipid Rafts?
by: Maja Grundner, et al.
Published: (2021-04-01)

Nose-to-brain selective drug delivery to glioma via ferritin-based nanovectors reduces tumor growth and improves survival rate
by: Francesco Marrocco, et al.
Published: (2024-04-01)

The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy
by: Gianni Frascotti, et al.
Published: (2021-02-01)

Assisted technology in Parkinson's disease gait: what's up?
by: Tamine T. C. Capato, et al.
Published: (2024-06-01)